FR2380780A2 - Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs - Google Patents

Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs

Info

Publication number
FR2380780A2
FR2380780A2 FR7718075A FR7718075A FR2380780A2 FR 2380780 A2 FR2380780 A2 FR 2380780A2 FR 7718075 A FR7718075 A FR 7718075A FR 7718075 A FR7718075 A FR 7718075A FR 2380780 A2 FR2380780 A2 FR 2380780A2
Authority
FR
France
Prior art keywords
oxazolidinones
hydroxymethyl
antidepressants
therapeutic application
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7718075A
Other languages
English (en)
Other versions
FR2380780B2 (fr
Inventor
Philippe Dostert
Colette Douzon
Guy Bourgery
Claude Gouret
Gisele Mocquet
Alain Coston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH219177A external-priority patent/CH618975A5/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of FR2380780A2 publication Critical patent/FR2380780A2/fr
Application granted granted Critical
Publication of FR2380780B2 publication Critical patent/FR2380780B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a. Application en thérapeutique de nouvelles hydroxyméthyl-5 oxazolidinones-2. b. Ces hydroxyméthyl-5 oxazolidinones-2 répondent à la formule :
FR7718075A 1977-02-22 1977-06-13 Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs Granted FR2380780A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219177A CH618975A5 (fr) 1976-03-01 1977-02-22

Publications (2)

Publication Number Publication Date
FR2380780A2 true FR2380780A2 (fr) 1978-09-15
FR2380780B2 FR2380780B2 (fr) 1981-05-29

Family

ID=4228019

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7718075A Granted FR2380780A2 (fr) 1977-02-22 1977-06-13 Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs
FR7726105A Granted FR2381037A2 (fr) 1977-02-22 1977-08-26 Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application therapeutique
FR7726104A Granted FR2381038A2 (fr) 1977-02-22 1977-08-26 Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2 leur procede de preparation et leur application en therapeutique

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7726105A Granted FR2381037A2 (fr) 1977-02-22 1977-08-26 Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application therapeutique
FR7726104A Granted FR2381038A2 (fr) 1977-02-22 1977-08-26 Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2 leur procede de preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (3) FR2380780A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413001A (en) * 1978-06-09 1983-11-01 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2528046B1 (fr) * 1982-06-08 1985-06-21 Delalande Sa Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation
TW286317B (fr) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE69616366T2 (de) * 1995-09-01 2002-07-04 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035024A1 (fr) * 1969-03-18 1970-12-18 Delalande Sa

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035024A1 (fr) * 1969-03-18 1970-12-18 Delalande Sa

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413001A (en) * 1978-06-09 1983-11-01 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones

Also Published As

Publication number Publication date
FR2381037B2 (fr) 1981-05-29
FR2381038B2 (fr) 1980-07-18
FR2380780B2 (fr) 1981-05-29
FR2381038A2 (fr) 1978-09-15
FR2381037A2 (fr) 1978-09-15

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
JO1502B1 (en) New pharmacy vehicles
IL138516A0 (en) Benzenesulfonamide derivatives and their use as medicaments
BG104849A (en) Indolyl-3-glyoxylic acid derivatives with antitumoral activity
KR920007629A (ko) SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
IE34746L (en) 2-(n-allyl-n-arylamino)-imidazolines
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
GR3025207T3 (en) 2-Formylpyridine thiosemicarbazone derivatives, their preparation and their use as antitumor agents
JPS6450819A (en) Antidementia agent
ROSNER Xanthoma of the choroid plexus in a child.
CA1267604A (fr) Methode de traitement des maladies neoplastiques
ES339483A1 (es) Un procedimiento para la obtencion de nuevas tetrahidro- quinazolinas sustituidas por halogenos.
DE69232014D1 (de) Amethocain enthaltende Arzneimittel
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
GB9420748D0 (en) 1,5 benzodiazepine derivatives
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57128625A (en) Carcinostatic
IE42230L (en) Pharmaceutical combination preparation
GB1340359A (en) Benzazepine derivatives their preparation and compositions containing them
ATE109003T1 (de) Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.
JPS5486628A (en) Analgesic antiphlogistic agent
JPS57114519A (en) Antiarteriosclerotic agent